Exploitation of Potentially New Antibiotics from Mangrove Actinobacteria in Maowei Sea by Combination of Multiple Discovery Strategies
Authors:
- Qin-Pei LuQLQin-Pei Lu
- Jing-Jing YeJYJing-Jing Ye
- Yong-Mei HuangYHYong-Mei Huang
- Di LiuDLDi Liu
- Li-Fang LiuLLLi-Fang Liu
- Kun DongKDKun Dong
- Elizaveta A. RazumovaERElizaveta A. Razumova
- Ilya A. OstermanIOIlya A. Osterman
- Petr V. SergievPSPetr V. Sergiev
- Olga A. DontsovaODOlga A. Dontsova
- Shu-Han JiaSJShu-Han Jia
- Da-Lin HuangDHDa-Lin Huang
Open Access
- 27 November 2019
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 8 (4) , 236
Abstract
Rediscovery of known antibiotics from actinobacteria, especially Streptomyces, has become a bottleneck issue. Nowadays, more specific identification and dereplication could be acquired by a combination of modern analytic techniques with various databases. In this study, 261 actinobacterial strains were isolated from 8 mangrove soil samples by culture-dependent method. A total of 83 strains were selected to evaluate antibacterial activities and mechanisms by disc diffusion method and a unique double fluorescent protein reporter system (pDualrep2), respectively. Thirty-two strains exhibited antagonistic activity against at least one of the “ESKAPE” pathogens. Four Streptomyces strains (B475, B486, B353, and B98) showed strong inhibitory activity against Gram-positive bacteria and induced DNA damage SOS response. One Micromonospora strain (B704) exhibited inhibitory activity against several pathogens and induced attenuation-based translational inhibitors reporter. Seven members of quinoxaline-type antibiotics including quinomycin A, quinomycin monosulfoxide, and other five putative new analogues were found from the culture broth of strain B475 by a combination of anti-MRSA guide, HPTLC, HPLC-UV, and UPLC-UV-HRESIMS/MS analysis, Chemspider searching, and MS/MS-based molecular networking analysis. In conclusion, this study not only demonstrated that mangrove is a rich source of actinobacteria with the potentially new antibiotics but showed rapid dereplication of known antibiotics in the early stage can improve efficiency for the discovery of new antibiotics.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (CAMS 2017-I2M-B&R-08)
- PUMC Doctoral Innovation Fund Project (2018-1007-16)
- Joint Grant from NSFC and RFBR (81611530716; 81460537; 17-53-53130)
- Russian Foundation for Basic Research (18-34-20055)
- Guangxi Key Laboratory Cultivation Base Construction Project (17-259-74)
This publication has 67 references indexed in Scilit:
- New antibiotics for bad bugs: where are we?Annals of Clinical Microbiology and Antimicrobials, 2013
- A cross-platform toolkit for mass spectrometry and proteomicsNature Biotechnology, 2012
- Mass spectral molecular networking of living microbial coloniesProceedings of the National Academy of Sciences, 2012
- Marine actinomycetes as an emerging resource for the drug development pipelinesJournal of Biotechnology, 2012
- Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in ChinaMarine Drugs, 2009
- Renaissance in antibacterial discovery from actinomycetesCurrent Opinion in Pharmacology, 2008
- Developing a new resource for drug discovery: marine actinomycete bacteriaNature Chemical Biology, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Basic local alignment search toolJournal of Molecular Biology, 1990
- A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequencesJournal of Molecular Evolution, 1980